Compare ARK Genomic Revolution ETF (ARKG) vs Warner Music Group Corp (WMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Warner Music Group Corp — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Warner Music Group Corp trades at $28.99 (market cap $15.12B). The key difference: Warner Music Group Corp pays a 2.62% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Warner Music Group Corp nearer its low. Which is the better fit depends on your goals.
| ARKG | WMG | |
|---|---|---|
Sector | Sector/Thematic | Media |
52-Week High | $43.57 | $34.72 |
52-Week Low | $23.09 | $23.65 |
Market Cap | — | $15.12B |
Enterprise Value | — | $19.32B |
Dividend Yield | — | 2.62% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Warner Music Group (WMG) trades at $28.99, down 0.51% on the day, with a bullish technical signal driven by moving averages but mixed oscillators. The company reported revenue growth to $6.71B in 2025, though net income margin declined to 5.44%. Recent acquisitions like Sureel AI highlight strategic moves in AI-driven music attribution. Analyst consensus is strongly bullish with a $40.40 price target, implying significant upside from current levels.
WMG presents a compelling growth story with solid revenue expansion and strategic AI investments, but faces risks from margin compression and competitive pressures. The stock's high P/E of 34.51 suggests premium valuation, yet strong analyst buy ratings and institutional interest support further upside potential if execution on catalog monetization and streaming growth continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
